| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 750 | 750 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| NOVOGEN LMT SPONS ADR | 346,141 | 8,360 |
| SHORE BANCSHARES | 1,817,060 | 2,158,962 |
| MEI PHARMA, INC | 17,071 | 4,571 |
| ENLINK MIDSTREAM | 498,524 | 203,715 |
| ATARA BIOTHERAPUTICS | 147,017 | 100,833 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| UNITED ACCEPTANCE NOTE RECEIVABLE | AT COST | 300,000 | 300,000 |
| Description | Amount |
|---|---|
| DECREASE IN UNREALIZED GAIN ON STOCK DONATION | 197,615 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FILING FEE | 250 | 250 | 0 | |
| BANK FEES | 4,072 | 4,072 | 0 | |
| POSTAGE | 8 | 8 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL EXCISE TAXES | 555 | 0 | 0 |